Search
Molecular switch linked to lineage plasticity, therapy resistance: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/june-prostate-cancer.html
Two genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report.
Tumor mutations may not predict response to immunotherapy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/may-tumor-mutations.html
The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern Medical Center reported in a retrospective study.
Match Day magic: UTSW students earn top residency spots : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/march-match-day.html
At exactly 11 a.m. Friday, surrounded by family, friends, and mentors, 224 members of UT Southwestern Medical School’s Class of 2024 – who all embarked on their medical education during the height of the COVID-19 pandemic – learned where they will continue their medical training.
Drug targeting clear cell renal cell carcinoma shows promising approach: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/april-drug-targeting.html
– In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center, a short interfering RNA (siRNA) drug directed to tumor cells, ARO-HIF2, effectively disrupted HIF2α, a key driver of clear cell renal cell carcinoma (ccRCC).
UTSW study finds it safe to give clot-busting drug to stroke patients who took blood thinners: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/clot-busting-drug.html
Stroke patients on long-term blood thinners who were given the clot-busting drug alteplase enjoyed better recoveries than those who did not receive the drug and had no increased risk of bleeding, a new study led by UTSW researchers shows.
New role for innate immune sensor: suppressing liver cancer: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/suppressing-liver-cancer.html
UT Southwestern researchers have found that a protein in the body’s innate immune system that responds to gut microbes can suppress the most common type of liver cancer.
UT Southwestern honored for Fulbright student involvement: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/fulbright-student-involvement.html
UT Southwestern Medical Center is among the Top Producing Institutions of 2021-2022 Fulbright Students in the U.S., and one of the top producers of U.S. Fulbright students among 4-year, special-focus institutions.
Simmons Cancer Center’s Dr. John Sweetenham to chair National Comprehensive Cancer Network Board of Directors: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/sweetenham-nccn.html
John Sweetenham, M.D., Associate Director for Clinical Affairs at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, has been elected Chair of the Board of Directors of the National Comprehensive Cancer Network (NCCN).
UTSW researchers and international collaborators find human protein that potently inhibits coronavirus: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/cancer-support-system.html
A protein produced by the human immune system can potently inhibit several coronaviruses, including the one behind the current COVID-19 outbreak, an international team of investigators reports today.
Big genome found in tiny forest defoliator: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/gypsy-moths.html
Drs. Don Gammon and Nick Grishin have sequenced the genomes of the European gypsy moth and its even more destructive cousin, the Asian gypsy moth.